Precigen to present at the 42nd annual j.p. morgan healthcare conference

Germantown, md., dec. 18, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will present a corporate and clinical overview at the 42nd annual j.p.
PGEN Ratings Summary
PGEN Quant Ranking